Michael Gelband’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
+50,000
New +$1.36M 0.01% 1042
2021
Q4
Sell
-1,625
Closed -$724K 2638
2021
Q3
$724K Sell
1,625
-250
-13% -$112K 0.01% 1192
2021
Q2
$884K Buy
1,875
+108
+6% +$64.4K 0.01% 1066
2021
Q1
$1.29M Sell
1,767
-4,788
-73% -$4.78M 0.02% 774
2020
Q4
$7.04M Buy
6,555
+5,318
+430% +$6.91M 0.07% 181
2020
Q3
$1.97M Buy
+1,237
New +$2.2M 0.04% 412
2020
Q2
Sell
-469
Closed -$1.39M 2064
2020
Q1
$1.39M Sell
469
-452
-49% -$735K 0.08% 239
2019
Q4
$892K Buy
+921
New +$1.11M 0.02% 601

Other funds holding VXX

Michael Gelband's VXX Position: Q2 2026 in Review

Michael Gelband opened a new position in iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2026: 50,000 shares worth $1.1M. The stake represents 0.01% of the portfolio and ranks #1042 among its holdings. This is a return to the name: Michael Gelband previously reported a position in VXX as recently as Q3 2021.

Michael Gelband first reported a position in VXX in Q4 2019 and has held it in 8 quarters since. The position peaked at $7.04M in Q4 2020. 71 funds tracked by Wall St. Rank hold VXX as of Q2 2026.

  • Michael Gelband held 50,000 shares of iPath Series B S&P 500 VIX Short-Term Futures ETN worth $1.1M as of Q2 2026.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN was a new Michael Gelband position in Q2 2026.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1042 holding.
  • Michael Gelband first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q4 2019 and has held it in 8 quarters since.
  • Michael Gelband's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $7.04M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.